Linagliptin

Linagliptin

Cat Number
API668270120
CAS Number
668270-12-0

For research use only. We do not supply to patients.

For pharmaceutical-grade products or other inquiries, please contact our experts.

CAS Number
668270-12-0
EINECS
620-351-9
Synonyms
Tradjenta;Ondero;BI-1356
Description
Linagliptin is a DPP-4 inhibitor developed by Boehringer Ingelheim for the treatment of type II diabetes. Linagliptin differs from other DPP-4 inhibitors in that it has a non-linear pharmacokinetic profile, is not primarily eliminated by the renal system, and obeys concentration dependant protein binding.
Molecular Formula
C25H28N8O2
Molecular Weight
472.5
Appearance
White to yellow solid
Melting Point
202 °C
Standard
In-house
Facility GMP
Qualification
CDE/DMF/USMF/ASMF/KOR
You Might Also Like
Mazdutide
Mazdutide

Cat NO.: API2259884030
CAS NO.: 2259884-03-0

View Details
Glyburide
Glyburide

Cat NO.: API10238218
CAS NO.: 10238-21-8

View Details
R-Lipoic Acid
R-Lipoic Acid

Cat NO.: API1200222
CAS NO.: 1200-22-2

View Details
Glipizide
Glipizide

Cat NO.: API29094619
CAS NO.: 29094-61-9

View Details
HOURS

Daily: 9.30 AM–6.00 PM
Sunday : 9.30 AM–1.00 PM
Holidays: Closed

Member of
dcat
CERTIFICATION
dcat
dcat dcat dcat dcat
Contact Us
USA

Tel:
Email:
Address:

 
Denmark

Tel:
Email:
Address:

WhatsAPP
WhatsAPP (Sales #1)
WhatsAPP
WhatsAPP (Sales #2)
WhatsAPP
WhatsAPP (Sales #3)

All our products are chemicals for research purposes only. We do not supply for human or veterinary applications.

Privacy Policy | Cookie Policy Copyright © Protheragen. All Rights Reserved.


WhatsAPP
Top